Overview
Fumihiko Ishikawa practices in Yokohama, Japan. Ishikawa is rated as an Experienced expert by MediFind in the treatment of Adult T-Cell Leukemia. Their top areas of expertise are Leukemia, Adult T-Cell Leukemia, Acute Myeloid Leukemia (AML), RUNX1 Familial Platelet Disorder, and Colostomy.
Their clinical research consists of co-authoring 59 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Adult T-Cell Leukemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Ishikawa isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Ishikawa isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaIshikawa isExperienced. Learn about Adult T-Cell Leukemia.
- ColostomyIshikawa isExperienced. Learn about Colostomy.
- Graft Versus Host Disease (GvHD)Ishikawa isExperienced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaIshikawa isExperienced. Learn about Leukemia.